首页 > 最新文献

European journal of hospital pharmacy : science and practice最新文献

英文 中文
Recommended doses of endovenous vancomycin are insufficient to achieve therapeutic concentrations in paediatric patients. 静脉内万古霉素的推荐剂量不足以达到儿科患者的治疗浓度。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2023-003694
Irene Aguilo Lafarga, María Pérez Moreno, Elena Herranz Bayo, Miriam Merchante Andreu, Rafael Huarte Lacunza

Objectives: Vancomycin therapeutic drug monitoring is challenging, especially in the paediatric population where evidence is scarce. The main objective of this study was to analyse the achievement of therapeutic concentrations of vancomycin in paediatric patients and to evaluate the current monitoring method (trough levels), doses used, and the time required to achieve target concentrations.

Methods: Paediatric patients on treatment and monitored with vancomycin from November 2019 to December 2021 were included. Those with only one determination of serum vancomycin concentration were excluded. Demographic variables, analytical and microbiological parameters and toxicity data were collected. Pharmacokinetic parameters were assessed at baseline and during treatment.

Results: 225 patients (40.9% female; 108 neonates, 49 infants and 68 children or adolescents) were included in the study. The main indications for vancomycin treatment were sepsis (33.9%) and fever of unknown origin (29.3%). Microbiological cultures were positive in 71.1%, mostly with Gram-positive bacteria (60.4%). Therapeutic levels of vancomycin were reached in only 20.1% of the participants in the first determination. After pharmacokinetic monitoring, 81.7% of patients reached therapeutic concentrations, requiring a 23% increase in the initial dose, a 2-day lag time and 1-2 dosage adjustments until the therapeutic concentration was reached. Of the total patients, 13 developed nephrotoxicity, nine neutropenia and one patient developed red man syndrome.

Conclusions: In our sample of paediatric patients, the recommended doses of vancomycin were insufficient to achieve therapeutic concentrations. Revision of the recommendations and/or a change in the method of pharmacokinetic monitoring is crucial to optimise treatment in this population.

目的:万古霉素治疗药物监测具有挑战性,尤其是在证据不足的儿科人群中。本研究的主要目的是分析万古霉素在儿科患者中治疗浓度的达标情况,并评估当前的监测方法(谷值)、所用剂量以及达到目标浓度所需的时间:方法:纳入2019年11月至2021年12月期间接受万古霉素治疗和监测的儿科患者。仅测定过一次血清万古霉素浓度的患者除外。收集了人口统计学变量、分析和微生物学参数以及毒性数据。结果:研究共纳入 225 名患者(40.9% 为女性;108 名新生儿、49 名婴儿和 68 名儿童或青少年)。万古霉素治疗的主要适应症是败血症(33.9%)和不明原因的发热(29.3%)。微生物培养结果呈阳性的占 71.1%,大部分为革兰氏阳性菌(60.4%)。在首次测定中,只有 20.1%的参与者的万古霉素达到了治疗水平。经过药代动力学监测后,81.7%的患者达到了治疗浓度,需要将初始剂量增加 23%,滞后 2 天,并调整 1-2 次剂量,直到达到治疗浓度。在所有患者中,13 人出现肾毒性,9 人出现中性粒细胞减少症,1 人出现红人综合征:结论:在我们抽样调查的儿科患者中,万古霉素的推荐剂量不足以达到治疗浓度。修订建议和/或改变药代动力学监测方法对于优化这一人群的治疗至关重要。
{"title":"Recommended doses of endovenous vancomycin are insufficient to achieve therapeutic concentrations in paediatric patients.","authors":"Irene Aguilo Lafarga, María Pérez Moreno, Elena Herranz Bayo, Miriam Merchante Andreu, Rafael Huarte Lacunza","doi":"10.1136/ejhpharm-2023-003694","DOIUrl":"10.1136/ejhpharm-2023-003694","url":null,"abstract":"<p><strong>Objectives: </strong>Vancomycin therapeutic drug monitoring is challenging, especially in the paediatric population where evidence is scarce. The main objective of this study was to analyse the achievement of therapeutic concentrations of vancomycin in paediatric patients and to evaluate the current monitoring method (trough levels), doses used, and the time required to achieve target concentrations.</p><p><strong>Methods: </strong>Paediatric patients on treatment and monitored with vancomycin from November 2019 to December 2021 were included. Those with only one determination of serum vancomycin concentration were excluded. Demographic variables, analytical and microbiological parameters and toxicity data were collected. Pharmacokinetic parameters were assessed at baseline and during treatment.</p><p><strong>Results: </strong>225 patients (40.9% female; 108 neonates, 49 infants and 68 children or adolescents) were included in the study. The main indications for vancomycin treatment were sepsis (33.9%) and fever of unknown origin (29.3%). Microbiological cultures were positive in 71.1%, mostly with Gram-positive bacteria (60.4%). Therapeutic levels of vancomycin were reached in only 20.1% of the participants in the first determination. After pharmacokinetic monitoring, 81.7% of patients reached therapeutic concentrations, requiring a 23% increase in the initial dose, a 2-day lag time and 1-2 dosage adjustments until the therapeutic concentration was reached. Of the total patients, 13 developed nephrotoxicity, nine neutropenia and one patient developed red man syndrome.</p><p><strong>Conclusions: </strong>In our sample of paediatric patients, the recommended doses of vancomycin were insufficient to achieve therapeutic concentrations. Revision of the recommendations and/or a change in the method of pharmacokinetic monitoring is crucial to optimise treatment in this population.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"474-479"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9414284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of polypharmacy with cognitive impairment in older trauma patients: a cross-sectional study. 多药治疗与老年创伤患者认知障碍的关系:一项横断面研究。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2022-003645
Caroline de Godoi Rezende Costa Molino, Lisa Rübel, Noemi Mantegazza, Heike A Bischoff-Ferrari, Gregor Freystaetter

Introduction: Few if any studies have been conducted to date on the association between polypharmacy and cognitive impairment among older trauma patients. Therefore, we investigated whether polypharmacy is associated with cognitive impairment in trauma patients aged ≥70 years.

Methods: This is a cross-sectional study of patients aged ≥70 years hospitalised due to a trauma-related injury. Cognitive impairment was defined as a Mini-Mental State Examination (MMSE) score ≤24 points. Medications were coded according to the Anatomical Therapeutic Chemical classification. Three exposures were examined: polypharmacy (≥5 medications), excessive polypharmacy (≥10 medications), and number of medications. Separate logistic regression models adjusted for age, sex, body mass index (BMI), education, smoking, independent living, frailty, multimorbidity, depression, and type of trauma were used to test the association between the three exposures and cognitive impairment.

Results: A total of 198 patients were included (mean age 80.2; 64.7% women and 35.4% men), of which 148 (74.8%) had polypharmacy and 63 (31.8%) had excessive polypharmacy. The prevalence of cognitive impairment was 34.3% overall, 37.2% in the polypharmacy group and 50.8% in the excessive polypharmacy group. More than 80% of participants were taking at least one analgesic. Overall, polypharmacy was not statistically significantly associated with cognitive impairment (odds ratio (OR) 1.20 [95% confidence interval (CI) 0.46 to 3.11]). However, patients in the excessive polypharmacy group were more than two times more likely to have cognitive impairment (OR 2.88 [95% CI 1.31 to 6.37]) even after adjustments for relevant confounders. Similarly, the number of medications was associated with greater odds of cognitive impairment (OR 1.15 [95% CI 1.04 to 1.28]) after adjustments for the same relevant confounders.

Conclusion: Cognitive impairment is common among older trauma patients, particularly among those in the excessive polypharmacy group. Polypharmacy was not associated with cognitive impairment. Excessive polypharmacy and number of medications, on the other hand, were associated with greater odds of cognitive impairment in older trauma patients.

导言:迄今为止,有关老年创伤患者多种药物治疗与认知障碍之间关系的研究很少,甚至没有。因此,我们研究了多种药物治疗是否与年龄≥70 岁的创伤患者的认知障碍有关:这是一项横断面研究,研究对象为年龄≥70 岁的因创伤住院的患者。认知障碍的定义是迷你精神状态检查(MMSE)得分≤24分。药物根据解剖治疗化学分类进行编码。研究了三种暴露情况:多药(≥5 种药物)、过度多药(≥10 种药物)和药物数量。分别使用调整了年龄、性别、体重指数(BMI)、教育程度、吸烟、独立生活、虚弱、多病症、抑郁和创伤类型的逻辑回归模型来检验这三种暴露与认知障碍之间的关系:共纳入了 198 名患者(平均年龄 80.2 岁;64.7% 为女性,35.4% 为男性),其中 148 人(74.8%)使用多种药物,63 人(31.8%)过度使用多种药物。认知障碍的发生率为 34.3%,多药组为 37.2%,过度多药组为 50.8%。80%以上的参与者至少服用一种镇痛药。总体而言,多药治疗与认知障碍没有明显的统计学关联(几率比(OR)为 1.20 [95%置信区间(CI)为 0.46 至 3.11])。然而,即使在调整了相关的混杂因素后,过度使用多种药物组患者出现认知障碍的几率仍比对照组高出两倍多(OR 2.88 [95% CI 1.31 至 6.37])。同样,在对相同的相关混杂因素进行调整后,药物数量也与认知障碍的几率增加有关(OR 1.15 [95% CI 1.04 至 1.28]):结论:认知障碍在老年创伤患者中很常见,尤其是在过度使用多种药物组中。多药治疗与认知障碍无关。而过度多药和药物数量则与老年创伤患者认知功能受损的几率增加有关。
{"title":"Association of polypharmacy with cognitive impairment in older trauma patients: a cross-sectional study.","authors":"Caroline de Godoi Rezende Costa Molino, Lisa Rübel, Noemi Mantegazza, Heike A Bischoff-Ferrari, Gregor Freystaetter","doi":"10.1136/ejhpharm-2022-003645","DOIUrl":"10.1136/ejhpharm-2022-003645","url":null,"abstract":"<p><strong>Introduction: </strong>Few if any studies have been conducted to date on the association between polypharmacy and cognitive impairment among older trauma patients. Therefore, we investigated whether polypharmacy is associated with cognitive impairment in trauma patients aged ≥70 years.</p><p><strong>Methods: </strong>This is a cross-sectional study of patients aged ≥70 years hospitalised due to a trauma-related injury. Cognitive impairment was defined as a Mini-Mental State Examination (MMSE) score ≤24 points. Medications were coded according to the Anatomical Therapeutic Chemical classification. Three exposures were examined: polypharmacy (≥5 medications), excessive polypharmacy (≥10 medications), and number of medications. Separate logistic regression models adjusted for age, sex, body mass index (BMI), education, smoking, independent living, frailty, multimorbidity, depression, and type of trauma were used to test the association between the three exposures and cognitive impairment.</p><p><strong>Results: </strong>A total of 198 patients were included (mean age 80.2; 64.7% women and 35.4% men), of which 148 (74.8%) had polypharmacy and 63 (31.8%) had excessive polypharmacy. The prevalence of cognitive impairment was 34.3% overall, 37.2% in the polypharmacy group and 50.8% in the excessive polypharmacy group. More than 80% of participants were taking at least one analgesic. Overall, polypharmacy was not statistically significantly associated with cognitive impairment (odds ratio (OR) 1.20 [95% confidence interval (CI) 0.46 to 3.11]). However, patients in the excessive polypharmacy group were more than two times more likely to have cognitive impairment (OR 2.88 [95% CI 1.31 to 6.37]) even after adjustments for relevant confounders. Similarly, the number of medications was associated with greater odds of cognitive impairment (OR 1.15 [95% CI 1.04 to 1.28]) after adjustments for the same relevant confounders.</p><p><strong>Conclusion: </strong>Cognitive impairment is common among older trauma patients, particularly among those in the excessive polypharmacy group. Polypharmacy was not associated with cognitive impairment. Excessive polypharmacy and number of medications, on the other hand, were associated with greater odds of cognitive impairment in older trauma patients.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"428-433"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9112970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administration. Stabilis 数据库的一项新功能:注射药物的物理兼容性和不兼容性,以确保 Y 型部位给药。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2022-003637
Benoît Beiler, Jean Vigneron, Elise D'Huart, Béatrice Demoré

Objectives: In intensive care units, the mixing of injectable drugs via Y-site administration is often necessary. However, some mixtures can lead to physical incompatibility or chemical instability. To assist healthcare professionals, several databases such as Stabilis compile compatibility and stability data. The objectives of this study were to update the online database Stabilis by adding physical compatibility data to the website and to characterise the incompatibility data already present in the database by specifying the phenomenon at the origin of the incompatibility and its time of occurrence.

Methods: Bibliographic sources referenced in Stabilis were evaluated using several criteria. After the evaluation, studies were rejected or the data they contain were added to the database. Data entries contained the following information: name of the two injectable drugs involved in the mixture and their concentration if available, the dilution solvent and the phenomenon at the origin of the incompatibility and its time of occurrence for incompatibility data. Three functions of the website were modified, including the 'Y-site compatibility table' function, which allows creation of customised compatibility tables.

Results: A total of 1184 bibliographic sources were evaluated, 77.3% (n=915) of which were scientific articles, 20.5% (n=243) were Summaries of Product Characteristics and 2.2% (n=26) were communications in a pharmaceutical congress. After evaluation, 28.9% (n=342) of the sources were rejected. From the 71.1% (n=842) sources selected, 8073 (70.2%) compatibility data entries and 3433 incompatibility data entries (29.8%) were made. With the addition of these data, the database contained compatibility and incompatibility data for 431 injectable drugs.

Conclusions: Since the update, the 'Y-site compatibility table' function has seen its traffic increased by about 66% (∼1500 tables per month compared with ∼2500 tables per month). Stabilis is now more complete to offer significant help to healthcare professionals with their problems of drug stability and compatibility.

目的:在重症监护病房,经常需要通过 Y 型给药混合注射药物。然而,有些混合物会导致物理不相容或化学不稳定。为了帮助医护人员,Stabilis 等多个数据库汇编了兼容性和稳定性数据。本研究的目的是更新在线数据库 Stabilis,在网站上添加物理相容性数据,并通过说明不相容现象的起因和发生时间来描述数据库中已有的不相容数据的特征:采用多种标准对 Stabilis 中引用的文献资料进行评估。评估结束后,研究报告将被剔除或将其中包含的数据添加到数据库中。数据条目包含以下信息:混合物中两种注射药物的名称及其浓度(如有)、稀释溶剂、不相容现象的起因以及不相容数据的出现时间。对网站的三项功能进行了修改,其中包括 "Y-网站兼容性表 "功能,该功能允许创建定制的兼容性表:共评估了 1184 个文献来源,其中 77.3%(n=915)为科学文章,20.5%(n=243)为产品特征概要,2.2%(n=26)为制药大会上的交流。经过评估,28.9%(n=342)的资料来源被拒绝。在 71.1%(n=842)被选中的数据源中,有 8073 条(70.2%)兼容数据和 3433 条(29.8%)不兼容数据。加入这些数据后,数据库包含了 431 种注射药物的兼容性和不兼容性数据:自更新以来,"Y-site 兼容性表 "功能的流量增加了约 66%(与每月 ∼2500 个表相比,每月 ∼1500 个表)。现在,Stabilis 的功能更加完善,可以为医疗保健专业人员解决药物稳定性和兼容性问题提供重要帮助。
{"title":"A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administration.","authors":"Benoît Beiler, Jean Vigneron, Elise D'Huart, Béatrice Demoré","doi":"10.1136/ejhpharm-2022-003637","DOIUrl":"10.1136/ejhpharm-2022-003637","url":null,"abstract":"<p><strong>Objectives: </strong>In intensive care units, the mixing of injectable drugs via Y-site administration is often necessary. However, some mixtures can lead to physical incompatibility or chemical instability. To assist healthcare professionals, several databases such as Stabilis compile compatibility and stability data. The objectives of this study were to update the online database Stabilis by adding physical compatibility data to the website and to characterise the incompatibility data already present in the database by specifying the phenomenon at the origin of the incompatibility and its time of occurrence.</p><p><strong>Methods: </strong>Bibliographic sources referenced in Stabilis were evaluated using several criteria. After the evaluation, studies were rejected or the data they contain were added to the database. Data entries contained the following information: name of the two injectable drugs involved in the mixture and their concentration if available, the dilution solvent and the phenomenon at the origin of the incompatibility and its time of occurrence for incompatibility data. Three functions of the website were modified, including the 'Y-site compatibility table' function, which allows creation of customised compatibility tables.</p><p><strong>Results: </strong>A total of 1184 bibliographic sources were evaluated, 77.3% (n=915) of which were scientific articles, 20.5% (n=243) were Summaries of Product Characteristics and 2.2% (n=26) were communications in a pharmaceutical congress. After evaluation, 28.9% (n=342) of the sources were rejected. From the 71.1% (n=842) sources selected, 8073 (70.2%) compatibility data entries and 3433 incompatibility data entries (29.8%) were made. With the addition of these data, the database contained compatibility and incompatibility data for 431 injectable drugs.</p><p><strong>Conclusions: </strong>Since the update, the 'Y-site compatibility table' function has seen its traffic increased by about 66% (∼1500 tables per month compared with ∼2500 tables per month). Stabilis is now more complete to offer significant help to healthcare professionals with their problems of drug stability and compatibility.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"461-467"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9145068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automation of parenteral nutrition: impact on process and cost analysis. 肠外营养的自动化:对流程和成本分析的影响。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2022-003602
Quentin Perrier, Amor Hosni, Julien Leenhardt, Marie-Dominique Desruet, Marjorie Durand, Pierrick Bedouch

Objectives: On the basis of its safety and accuracy, automation is recommended for parenteral nutrition (PN). The aim of this study was to highlight the changes in practices related to the automation of PN and to perform a cost study comparing manual vs automated production costs.

Methods: We conducted a micro-costing study using 1 year of manual production data for adult, neonatal and paediatric PN bagsat a hospital. We used the data to estimate the costs of automating the production process for adult, neonatal and paediatric bags.

Results: Major modification to the PN production process resulted in: rationalisation of raw materials, computerisation and optimisation of human needs. Switching from a manual to an automated process reduced the cost of neonatal/paediatric custom bags (€130.73 vs €124.58) and semi-custom bags (€172.08 vs €166.86); but increased the cost of adult bags (€93.06 vs €127.92).

Conclusions: The changes resulting from the automation and revision of the production process globally increased annual expenditures by approximately 9.7%. However, automation minimised the risk of misproduction, bag contamination, and led to a more secure production process that reduced risks incurred by the teams. In view of the gain in patient and staff safety (linked to the use of an automated compounding device) the moderate economic impact (<10%) should not deter the automation of PN production circuits.

目的:基于安全性和准确性,建议对肠外营养液(PN)进行自动化处理。本研究旨在强调与肠外营养液自动化相关的实践变化,并对人工与自动化生产成本进行成本研究:我们利用一家医院一年来的成人、新生儿和儿科 PN 袋人工生产数据进行了一项微观成本研究。我们利用这些数据估算了成人、新生儿和儿科 PN 袋自动化生产过程的成本:对 PN 生产流程的重大改造包括:原材料合理化、计算机化和人力需求优化。从手工流程到自动化流程的转变降低了新生儿/儿科定制袋的成本(130.73 欧元对 124.58 欧元)和半定制袋的成本(172.08 欧元对 166.86 欧元),但增加了成人袋的成本(93.06 欧元对 127.92 欧元):自动化和生产流程调整带来的变化使全球每年的支出增加了约 9.7%。然而,自动化生产最大程度地降低了错误生产和药袋污染的风险,使生产流程更加安全,从而降低了团队的风险。鉴于病人和员工安全的提高(与使用自动化配制设备有关),适度的经济影响 (
{"title":"Automation of parenteral nutrition: impact on process and cost analysis.","authors":"Quentin Perrier, Amor Hosni, Julien Leenhardt, Marie-Dominique Desruet, Marjorie Durand, Pierrick Bedouch","doi":"10.1136/ejhpharm-2022-003602","DOIUrl":"10.1136/ejhpharm-2022-003602","url":null,"abstract":"<p><strong>Objectives: </strong>On the basis of its safety and accuracy, automation is recommended for parenteral nutrition (PN). The aim of this study was to highlight the changes in practices related to the automation of PN and to perform a cost study comparing manual vs automated production costs.</p><p><strong>Methods: </strong>We conducted a micro-costing study using 1 year of manual production data for adult, neonatal and paediatric PN bagsat a hospital. We used the data to estimate the costs of automating the production process for adult, neonatal and paediatric bags.</p><p><strong>Results: </strong>Major modification to the PN production process resulted in: rationalisation of raw materials, computerisation and optimisation of human needs. Switching from a manual to an automated process reduced the cost of neonatal/paediatric custom bags (€130.73 vs €124.58) and semi-custom bags (€172.08 vs €166.86); but increased the cost of adult bags (€93.06 vs €127.92).</p><p><strong>Conclusions: </strong>The changes resulting from the automation and revision of the production process globally increased annual expenditures by approximately 9.7%. However, automation minimised the risk of misproduction, bag contamination, and led to a more secure production process that reduced risks incurred by the teams. In view of the gain in patient and staff safety (linked to the use of an automated compounding device) the moderate economic impact (<10%) should not deter the automation of PN production circuits.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"468-473"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9673193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimisation of the quality of care for patients with severe asthma: ASfarMA project. 优化重症哮喘患者的护理质量:ASfarMA 项目。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2022-003611
María Muñoz-García, Hilario Martínez-Barros, Silvia Sánchez-Cuéllar, Ana Morales-Tirado, Ana De-Andrés-Martín, Gonzalo De-Los-Santos-Granados, Darío Antolín-Amérigo, Enrique Blitz-Castro, Patricia Fernández-Martín, Alfonso Santamaría-Gadea, Belén De-La-Hoz-Caballer, Ana María Álvarez-Díaz, David González-De-Olano

 Severe asthma has an important impact on patients and healthcare resources. Recently, the new specific treatments have defined a new scenario in which person-focused care and specialist multidisciplinary teams are necessary. Our Severe Asthma Unit (SAU) started the ASfarMA project along with an external human-centered design company to understand patients' vision of their illness, treatment, and healthcare experience, and to define the ideal SAU by performing a core group session, in-depth semistructured interviews and co-creation workshop. Herein, a series of tips classified as either 'transformative solutions' or 'quick wins', according to a value versus effort matrix are presented. Successful implementation of the proposed solutions will be valuable for patients and healthcare professionals, optimising patient care and resources. These findings can also be helpful to other SAUs or other humanisation projects involving complex, chronic and multidisciplinary pathologies.

严重哮喘对患者和医疗资源造成了重大影响。最近,新的特殊治疗方法确定了一种新的情况,即需要以人为本的护理和专业的多学科团队。我们的重症哮喘科(SAU)与一家外部以人为本的设计公司共同启动了 ASfarMA 项目,以了解患者对其疾病、治疗和医疗体验的看法,并通过核心小组会议、深入的半结构式访谈和共同创造研讨会来定义理想的 SAU。在此,根据价值与努力矩阵,提出了一系列 "变革性解决方案 "或 "速赢 "建议。建议解决方案的成功实施对患者和医护人员都很有价值,可优化患者护理和资源。这些发现对其他涉及复杂、慢性和多学科病症的 SAU 或其他人性化项目也有帮助。
{"title":"Optimisation of the quality of care for patients with severe asthma: ASfarMA project.","authors":"María Muñoz-García, Hilario Martínez-Barros, Silvia Sánchez-Cuéllar, Ana Morales-Tirado, Ana De-Andrés-Martín, Gonzalo De-Los-Santos-Granados, Darío Antolín-Amérigo, Enrique Blitz-Castro, Patricia Fernández-Martín, Alfonso Santamaría-Gadea, Belén De-La-Hoz-Caballer, Ana María Álvarez-Díaz, David González-De-Olano","doi":"10.1136/ejhpharm-2022-003611","DOIUrl":"10.1136/ejhpharm-2022-003611","url":null,"abstract":"<p><p> Severe asthma has an important impact on patients and healthcare resources. Recently, the new specific treatments have defined a new scenario in which person-focused care and specialist multidisciplinary teams are necessary. Our Severe Asthma Unit (SAU) started the ASfarMA project along with an external human-centered design company to understand patients' vision of their illness, treatment, and healthcare experience, and to define the ideal SAU by performing a core group session, in-depth semistructured interviews and co-creation workshop. Herein, a series of tips classified as either 'transformative solutions' or 'quick wins', according to a value versus effort matrix are presented. Successful implementation of the proposed solutions will be valuable for patients and healthcare professionals, optimising patient care and resources. These findings can also be helpful to other SAUs or other humanisation projects involving complex, chronic and multidisciplinary pathologies.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"480-482"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10637453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and evaluation of a blended learning training programme for pharmacy technicians' continuing education. 药剂师继续教育混合学习培训计划的开发与评估。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2022-003679
Audrey Flornoy-Guédon, Caroline Fonzo-Christe, Emy Meier, Marianne Gazengel-Marchand, Olivia Francois, Liliane Gschwind, Pascal Bonnabry

Objectives: The role of the pharmacy technician (PT) has expanded in recent years, requiring new competencies, better communications skills and high-level knowledge about drugs. The objective of this study is to develop and evaluate a blended learning programme for PTs' continuing professional development.

Methods: A blended learning programme designed to enhance knowledge, skills and attitudes was created using a six-step approach to curriculum development for medical education. The first part included three short microlearning videos to improve knowledge; the second consisted of a 1.5 hour 'edutainment' session for groups of 5-6 PTs to deepen their knowledge and practice skills. Impacts on knowledge, degree of certainty and self-perceived competence were evaluated before training (pre-test), after the microlearning (post-test 1) and after the edutainment session (post-test 2).

Results: The three microlearnings were entitled 'Communication', 'Cut-crush a tablet/open a capsule' and 'Pharmacy website'. The edutainment session used team-based learning, game-based learning, peer instruction and simulation. Twenty-six PTs of mean±SD age 36±8 years participated. Pre-test and post-test 1 evaluation scores showed significant overall improvements in mean knowledge (9.1/18 vs 12.1/18, p<0.001), mean degree of certainty (3.4/5 vs 4.2/5, p<0.001) and mean self-perceived competence (58.6/100 vs 72.3/100, p<0.001). After post-test 2, mean knowledge (12.1/18 vs 13.1/18, p=0.010) and mean self-perceived competence (72.3/100 vs 81.1/100, p=0.001) scores had improved, but not mean degree of certainty (4.2/5 vs 4.4/5, p=0.105). All participants found the blended learning programme suitable for their continuing professional development.

Conclusions: The present study showed the positive effects of using our blended learning programme to improve PTs' knowledge, degree of certainty and self-perceived competence, to their great satisfaction. This pedagogical format will be integrated into PTs' continuing professional development and include other educational topics.

目标:近年来,药房技术员(PT)的职责不断扩大,需要具备新的能力、更好的沟通技巧和高水平的药物知识。本研究的目的是为药剂师的持续专业发展制定和评估一项混合学习计划:方法:采用医学教育课程开发的六步方法,设计了一个混合学习课程,旨在提高知识、技能和态度。第一部分包括三个微型学习视频短片,以提高知识水平;第二部分包括一个1.5小时的 "寓教于乐 "课程,由5-6名PT组成小组,以加深他们的知识和实践技能。分别在培训前(前测试)、微型学习后(后测试 1)和寓教于乐课程后(后测试 2)评估了对知识、确定程度和自我认知能力的影响:三个微型学习的题目分别是 "交流"、"切碎药片/打开胶囊 "和 "药房网站"。寓教于乐的课程采用了团队学习、游戏学习、同伴指导和模拟教学等方式。共有 26 名实习医生参加,平均年龄(±SD)为 36±8 岁。前测和后测 1 的评估得分显示,平均知识水平总体上有显著提高(9.1/18 vs 12.1/18,p 结论:本研究表明,使用我们的混合式学习方案对提高护理人员的知识水平、确定性和自我认知能力有积极作用,他们对此非常满意。这种教学形式将纳入护理人员的持续专业发展,并包括其他教育主题。
{"title":"Development and evaluation of a blended learning training programme for pharmacy technicians' continuing education.","authors":"Audrey Flornoy-Guédon, Caroline Fonzo-Christe, Emy Meier, Marianne Gazengel-Marchand, Olivia Francois, Liliane Gschwind, Pascal Bonnabry","doi":"10.1136/ejhpharm-2022-003679","DOIUrl":"10.1136/ejhpharm-2022-003679","url":null,"abstract":"<p><strong>Objectives: </strong>The role of the pharmacy technician (PT) has expanded in recent years, requiring new competencies, better communications skills and high-level knowledge about drugs. The objective of this study is to develop and evaluate a blended learning programme for PTs' continuing professional development.</p><p><strong>Methods: </strong>A blended learning programme designed to enhance knowledge, skills and attitudes was created using a six-step approach to curriculum development for medical education. The first part included three short microlearning videos to improve knowledge; the second consisted of a 1.5 hour 'edutainment' session for groups of 5-6 PTs to deepen their knowledge and practice skills. Impacts on knowledge, degree of certainty and self-perceived competence were evaluated before training (pre-test), after the microlearning (post-test 1) and after the edutainment session (post-test 2).</p><p><strong>Results: </strong>The three microlearnings were entitled 'Communication', 'Cut-crush a tablet/open a capsule' and 'Pharmacy website'. The edutainment session used team-based learning, game-based learning, peer instruction and simulation. Twenty-six PTs of mean±SD age 36±8 years participated. Pre-test and post-test 1 evaluation scores showed significant overall improvements in mean knowledge (9.1/18 vs 12.1/18, p<0.001), mean degree of certainty (3.4/5 vs 4.2/5, p<0.001) and mean self-perceived competence (58.6/100 vs 72.3/100, p<0.001). After post-test 2, mean knowledge (12.1/18 vs 13.1/18, p=0.010) and mean self-perceived competence (72.3/100 vs 81.1/100, p=0.001) scores had improved, but not mean degree of certainty (4.2/5 vs 4.4/5, p=0.105). All participants found the blended learning programme suitable for their continuing professional development.</p><p><strong>Conclusions: </strong>The present study showed the positive effects of using our blended learning programme to improve PTs' knowledge, degree of certainty and self-perceived competence, to their great satisfaction. This pedagogical format will be integrated into PTs' continuing professional development and include other educational topics.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"403-408"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9454840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements. 提高临床和社会药学实践研究的出版物质量并推进其范式:格拉纳达声明。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2023-003748
Fernando Fernandez-Llimos, Shane Desselle, Derek Stewart, Victoria Garcia-Cardenas, Zaheer-Ud-Din Babar, Christine Bond, Ana Dago, Ramune Jacobsen, Lotte Stig Nørgaard, Carlo Polidori, Manuel Sanchez-Polo, Bernardo Santos-Ramos, Natalia G Shcherbakova, Fernanda S Tonin

Pharmacy and pharmaceutical sciences embrace a series of different disciplines. Pharmacy practice has been defined as 'the scientific discipline that studies the different aspects of the practice of pharmacy and its impact on healthcare systems, medicine use, and patient care'. Thus, pharmacy practice studies embrace both clinical pharmacy and social pharmacy elements. Like any other scientific discipline, clinical and social pharmacy practice disseminates research findings using scientific journals. Clinical pharmacy and social pharmacy journal editors have a role in promoting the discipline by enhancing the quality of the articles published. As has occurred in other healthcare areas (ie, medicine and nursing), a group of clinical and social pharmacy practice journal editors gathered in Granada, Spain to discuss how journals could contribute to strengthening pharmacy practice as a discipline. The result of that meeting was compiled in these Granada Statements, which comprise 18 recommendations gathered into six topics: the appropriate use of terminology, impactful abstracts, the required peer reviews, journal scattering, more effective and wiser use of journal and article performance metrics, and authors' selection of the most appropriate pharmacy practice journal to submit their work.

药学和药学包含一系列不同的学科。药学实践被定义为“研究药学实践的不同方面及其对医疗保健系统、药物使用和患者护理的影响的科学学科”。因此,药学实践研究包括临床药学和社会药学两个方面。与任何其他科学学科一样,临床和社会药学实践使用科学期刊传播研究结果。临床药学和社会药学期刊编辑通过提高发表文章的质量,在促进学科发展方面发挥着重要作用。正如其他医疗保健领域(即医学和护理)所发生的那样,一群临床和社会药学实践期刊编辑聚集在西班牙格拉纳达,讨论期刊如何有助于加强药学实践这一学科。该会议的结果汇编在这些格拉纳达声明中,其中包括18项建议,共分为六个主题:术语的适当使用、有影响力的摘要、所需的同行评审、期刊分散、更有效和更明智地使用期刊和文章绩效指标、,以及作者选择最合适的药学实践期刊来提交他们的工作。
{"title":"Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements.","authors":"Fernando Fernandez-Llimos, Shane Desselle, Derek Stewart, Victoria Garcia-Cardenas, Zaheer-Ud-Din Babar, Christine Bond, Ana Dago, Ramune Jacobsen, Lotte Stig Nørgaard, Carlo Polidori, Manuel Sanchez-Polo, Bernardo Santos-Ramos, Natalia G Shcherbakova, Fernanda S Tonin","doi":"10.1136/ejhpharm-2023-003748","DOIUrl":"10.1136/ejhpharm-2023-003748","url":null,"abstract":"<p><p>Pharmacy and pharmaceutical sciences embrace a series of different disciplines. Pharmacy practice has been defined as 'the scientific discipline that studies the different aspects of the practice of pharmacy and its impact on healthcare systems, medicine use, and patient care'. Thus, pharmacy practice studies embrace both clinical pharmacy and social pharmacy elements. Like any other scientific discipline, clinical and social pharmacy practice disseminates research findings using scientific journals. Clinical pharmacy and social pharmacy journal editors have a role in promoting the discipline by enhancing the quality of the articles published. As has occurred in other healthcare areas (ie, medicine and nursing), a group of clinical and social pharmacy practice journal editors gathered in Granada, Spain to discuss how journals could contribute to strengthening pharmacy practice as a discipline. The result of that meeting was compiled in these Granada Statements, which comprise 18 recommendations gathered into six topics: the appropriate use of terminology, impactful abstracts, the required peer reviews, journal scattering, more effective and wiser use of journal and article performance metrics, and authors' selection of the most appropriate pharmacy practice journal to submit their work.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"483-488"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Call for emergency action to limit global temperature increases, restore biodiversity and protect health. 呼吁采取紧急行动,限制全球气温上升、恢复生物多样性和保护健康。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2021-003026
Lukoye Atwoli, Abdullah H Baqui, Thomas Benfield, Raffaella Bosurgi, Fiona Godlee, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Carlos Augusto Monteiro, Ian Norman, Kirsten Patrick, Nigel Praities, Marcel Gm Olde Rikkert, Eric J Rubin, Peush Sahni, Richard Smith, Nicholas J Talley, Sue Turale, Damián Vázquez
{"title":"Call for emergency action to limit global temperature increases, restore biodiversity and protect health.","authors":"Lukoye Atwoli, Abdullah H Baqui, Thomas Benfield, Raffaella Bosurgi, Fiona Godlee, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Carlos Augusto Monteiro, Ian Norman, Kirsten Patrick, Nigel Praities, Marcel Gm Olde Rikkert, Eric J Rubin, Peush Sahni, Richard Smith, Nicholas J Talley, Sue Turale, Damián Vázquez","doi":"10.1136/ejhpharm-2021-003026","DOIUrl":"10.1136/ejhpharm-2021-003026","url":null,"abstract":"","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"387-389"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39387535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die. 甲硝唑和双硫仑诱发的中毒性代谢性脑病:经典永存。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2024-004184
Maria Choví-Trull, Octavio Ballesta-López, Gema Amparo Navarro Buendia, Rafael Sivera-Mascaró, Asunción Albert-Marí, Maria Jose Ruiz Caldes, Javier Garcia-Pellicer, José Luis Poveda-Andrés

A 53-year-old male with recovering alcohol dependency, diagnosed with bipolar disorder and recurrent episodes of diverticulitis, came to the emergency department with disorientation and confusion after 3 days of treatment with metronidazole 250 mg/12 hours and ciprofloxacin 500 mg/12 hours for acute diverticulitis. In the hospital emergency department, he presented moments of agitation, fluctuations of attitude, increased basal tremor, with rhythmic movement of the left arm and leg, as well as generalised rigidity with an episode of tonic-clonic seizure of 1.5-2 min duration. After performing different diagnostic tests, significant brain findings were ruled out. The pharmacy department recommended the discontinuation of one of the two drugs. As a result, the on-call doctor adjusted the patient's treatment: disulfiram and previous antibiotic therapy (metronidazole and ciprofloxacin) were discontinued, and amoxicillin/clavulanic acid 2 g/8 hour was prescribed instead. The patient progressed well and fully recovered.

一名 53 岁的男性患者正在恢复酒精依赖,被诊断患有躁郁症和反复发作的憩室炎,在接受甲硝唑 250 毫克/12 小时和环丙沙星 500 毫克/12 小时的急性憩室炎治疗 3 天后,因神志不清和精神错乱来到急诊科就诊。在医院急诊科,他表现出躁动不安、情绪起伏不定、基础震颤加剧、左臂和左腿有节律地运动以及全身僵硬,并伴有持续 1.5-2 分钟的强直-阵挛发作。在进行了各种诊断性检查后,排除了重大脑部病变的可能性。药剂部门建议停用两种药物中的一种。因此,值班医生调整了患者的治疗方案:停用双硫仑和之前的抗生素治疗(甲硝唑和环丙沙星),改用阿莫西林/克拉维酸 2 克/8 小时。患者病情进展顺利,完全康复。
{"title":"Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.","authors":"Maria Choví-Trull, Octavio Ballesta-López, Gema Amparo Navarro Buendia, Rafael Sivera-Mascaró, Asunción Albert-Marí, Maria Jose Ruiz Caldes, Javier Garcia-Pellicer, José Luis Poveda-Andrés","doi":"10.1136/ejhpharm-2024-004184","DOIUrl":"https://doi.org/10.1136/ejhpharm-2024-004184","url":null,"abstract":"<p><p>A 53-year-old male with recovering alcohol dependency, diagnosed with bipolar disorder and recurrent episodes of diverticulitis, came to the emergency department with disorientation and confusion after 3 days of treatment with metronidazole 250 mg/12 hours and ciprofloxacin 500 mg/12 hours for acute diverticulitis. In the hospital emergency department, he presented moments of agitation, fluctuations of attitude, increased basal tremor, with rhythmic movement of the left arm and leg, as well as generalised rigidity with an episode of tonic-clonic seizure of 1.5-2 min duration. After performing different diagnostic tests, significant brain findings were ruled out. The pharmacy department recommended the discontinuation of one of the two drugs. As a result, the on-call doctor adjusted the patient's treatment: disulfiram and previous antibiotic therapy (metronidazole and ciprofloxacin) were discontinued, and amoxicillin/clavulanic acid 2 g/8 hour was prescribed instead. The patient progressed well and fully recovered.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Game-based training to promote handwashing, handrub and gloving for hospital pharmacy operators. 基于游戏的培训,促进医院药房操作员洗手、擦手和戴手套。
IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-08-22 DOI: 10.1136/ejhpharm-2022-003648
Alexandra Garnier, Christian Dubs, Clemens Haerder, Pascal Bonnabry, Lucie Bouchoud

Objectives: Adherence to handwashing, handrub and gloving procedures is mandatory for safe, aseptic drug compounding in hospital pharmacies. This study measured participants' satisfaction and effectiveness of a game-based training tool (Handtastic Box) developed to improve adherence.

Methods: Handtastic Boxes were played by pairs of pharmacy operators (introductory video, 1 min study of guidelines, game). In module 1, players watched videos of somebody handwashing and had to find the missing step. They examined wooden models of hands under ultraviolet (UV) light, with some areas stained with fluorescein, to find the hand showing contamination. In module 2, players used a fluorescein hydroalcoholic solution and placed their hands under UV light to highlight missing areas. In module 3, players identified major errors that could compromise glove sterility and linked them to a problem explanation. Then, they applied paint to their fingertips and donned gloves-the paint had to stay inside them. Satisfaction about the training was assessed with a 10-question survey; knowledge about procedures was assessed using a before-and-after questionnaire of nine questions, a 100-point confidence score (modules 1 and 2), and the number of before-and-after errors made during donning gloves (module 3).

Results: Operators were very satisfied and felt more competent after training. Average knowledge score increased from 56.3% (SD 18.2%) to 93.7% (SD 9.5%), and confidence in answers increased from 66.4% (SD 18.7%) to 95.7% (SD 5.52%) (n=14, both modules 1 and 2). The mean error score for gloving procedure decreased from 1.7 (SD 0.8%) to 0.3 (SD 0.5%) (n=10, module 3).

Conclusion: Handtastic Boxes proved to be a highly effective training method for improving knowledge of handwashing, handrub and gloving.

目的:遵守洗手、擦手和戴手套程序是医院药房安全无菌配制药物的必备条件。本研究测量了参与者对为提高遵守率而开发的基于游戏的培训工具(Handtastic Box)的满意度和有效性。方法:药房操作员两人一组玩 Handtastic Box(介绍视频、1 分钟指南学习、游戏)。在模块 1 中,参与者观看某人洗手的视频,并找出缺少的步骤。他们在紫外线(UV)照射下,用荧光素对手部的某些区域进行染色,检查木质手部模型,以找到被污染的那只手。在模块 2 中,选手们使用荧光素水醇溶液,将手放在紫外线下照射,以突出缺失的区域。在模块 3 中,选手们找出可能影响手套无菌性的主要错误,并将其与问题解释联系起来。然后,他们在指尖涂上颜料并戴上手套--颜料必须留在手套内。对培训满意度的评估包括 10 个问题的调查;对程序知识的评估包括 9 个问题的前后问卷、100 分的信心分(模块 1 和 2)以及戴手套时前后出错的次数(模块 3):结果:操作员对培训非常满意,并认为培训后更有能力胜任工作。平均知识得分从 56.3%(标准差 18.2%)增至 93.7%(标准差 9.5%),对答案的信心从 66.4%(标准差 18.7%)增至 95.7%(标准差 5.52%)(人数=14,模块 1 和 2)。手套操作的平均错误率从 1.7(标准差 0.8%)降至 0.3(标准差 0.5%)(人数=10,模块 3):事实证明,"Handtastic Boxes "是提高洗手、搓手和手套操作知识的一种非常有效的培训方法。
{"title":"Game-based training to promote handwashing, handrub and gloving for hospital pharmacy operators.","authors":"Alexandra Garnier, Christian Dubs, Clemens Haerder, Pascal Bonnabry, Lucie Bouchoud","doi":"10.1136/ejhpharm-2022-003648","DOIUrl":"10.1136/ejhpharm-2022-003648","url":null,"abstract":"<p><strong>Objectives: </strong>Adherence to handwashing, handrub and gloving procedures is mandatory for safe, aseptic drug compounding in hospital pharmacies. This study measured participants' satisfaction and effectiveness of a game-based training tool (Handtastic Box) developed to improve adherence.</p><p><strong>Methods: </strong>Handtastic Boxes were played by pairs of pharmacy operators (introductory video, 1 min study of guidelines, game). In module 1, players watched videos of somebody handwashing and had to find the missing step. They examined wooden models of hands under ultraviolet (UV) light, with some areas stained with fluorescein, to find the hand showing contamination. In module 2, players used a fluorescein hydroalcoholic solution and placed their hands under UV light to highlight missing areas. In module 3, players identified major errors that could compromise glove sterility and linked them to a problem explanation. Then, they applied paint to their fingertips and donned gloves-the paint had to stay inside them. Satisfaction about the training was assessed with a 10-question survey; knowledge about procedures was assessed using a before-and-after questionnaire of nine questions, a 100-point confidence score (modules 1 and 2), and the number of before-and-after errors made during donning gloves (module 3).</p><p><strong>Results: </strong>Operators were very satisfied and felt more competent after training. Average knowledge score increased from 56.3% (SD 18.2%) to 93.7% (SD 9.5%), and confidence in answers increased from 66.4% (SD 18.7%) to 95.7% (SD 5.52%) (n=14, both modules 1 and 2). The mean error score for gloving procedure decreased from 1.7 (SD 0.8%) to 0.3 (SD 0.5%) (n=10, module 3).</p><p><strong>Conclusion: </strong>Handtastic Boxes proved to be a highly effective training method for improving knowledge of handwashing, handrub and gloving.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":"423-427"},"PeriodicalIF":1.6,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9180519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European journal of hospital pharmacy : science and practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1